Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-30

Clinical Trial Update: Estrogen Treatment (Oral vs. Patches) in Turner Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral estrogen to estrogen delivered via skin patches in Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estradiol (oral) (estradiol)
  • Estradiol transdermal patch (estradiol)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Turner Syndrome, Hypogonadism | Phase 3 | Status: COMPLETED